Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis
- PMID: 32434481
- PMCID: PMC7240929
- DOI: 10.1186/s12885-020-06966-3
Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis
Abstract
Background: Activated eosinophils have been deemed to affect carcinogenesis and tumor progression via various mechanisms in tumor microenvironment. However, the prognostic role of tumor-associated tissue eosinophilia (TATE) in human cancers remains controversial. Therefore, we conducted this meta-analysis to better comprehend the association between TATE and clinical outcomes of patients.
Methods: We searched PubMed, Embase and EBSCO to determine the researches assessing the association between TATE and overall survival (OS) and/or disease-free survival (DFS) in patients with cancer, then combined relevant data into hazard ratios (HRs) or odds ratio (OR) for OS, DFS and clinicopathological features including lymph node metastasis etc. with STATA 12.0.
Results: Twenty six researches with 6384 patients were included in this meta-analysis. We found that the presence of TATE was significantly associated with improved OS, but not with DFS in all types of cancers. In stratified analyses based on cancer types, pooled results manifested that the infiltration of eosinophils was remarkably associated with better OS in esophageal carcinoma and colorectal cancer. In addition, TATE significantly inversely correlated with lymph node metastasis, tumor stage and lymphatic invasion of cancer.
Conclusion: TATE promotes survival in cancer patients, suggesting that it is a valuable prognostic biomarker and clinical application of biological response modifiers or agonists promoting TATE may be the novel therapeutic strategy for patients.
Keywords: Favorable outcome; Human solid tumor; Meta-analysis; Tumor-associated tissue eosinophilia.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Tumor-Infiltrating Podoplanin+ Fibroblasts Predict Worse Outcome in Solid Tumors.Cell Physiol Biochem. 2018;51(3):1041-1050. doi: 10.1159/000495484. Epub 2018 Nov 26. Cell Physiol Biochem. 2018. PMID: 30476924
-
Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma.Neoplasia. 2023 Jan;35:100855. doi: 10.1016/j.neo.2022.100855. Epub 2022 Nov 19. Neoplasia. 2023. PMID: 36410227 Free PMC article.
-
Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis.J Oral Biol Craniofac Res. 2021 Jan-Mar;11(1):33-39. doi: 10.1016/j.jobcr.2020.11.012. Epub 2020 Nov 23. J Oral Biol Craniofac Res. 2021. PMID: 33344159 Free PMC article. Review.
-
Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis.Front Physiol. 2018 Apr 26;9:452. doi: 10.3389/fphys.2018.00452. eCollection 2018. Front Physiol. 2018. PMID: 29765332 Free PMC article.
-
New Insights Into the Role of Tissue Eosinophils in the Progression of Colorectal Cancer: A Literature Review.Acta Med Port. 2018 Jun 29;31(6):329-337. doi: 10.20344/amp.10112. Epub 2018 Jun 29. Acta Med Port. 2018. PMID: 30020878 Review.
Cited by
-
Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.Oncol Res. 2023 Dec 28;32(2):339-351. doi: 10.32604/or.2023.030887. eCollection 2023. Oncol Res. 2023. PMID: 38186570 Free PMC article.
-
An increased relative eosinophil count as a predictive dynamic biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.Thorac Cancer. 2024 Jan;15(3):248-257. doi: 10.1111/1759-7714.15191. Epub 2023 Dec 12. Thorac Cancer. 2024. PMID: 38087769 Free PMC article.
-
Ultrastructural Evidence of Eosinophil Clustering and ETosis in Association with Damage to Single Tumour Cells in a Case of Poorly Cohesive NOS Gastric Carcinoma.Eur J Case Rep Intern Med. 2023 Aug 31;10(10):004016. doi: 10.12890/2023_004016. eCollection 2023. Eur J Case Rep Intern Med. 2023. PMID: 37789981 Free PMC article.
-
Eosinophils in the tumor microenvironment: implications for cancer immunotherapy.J Transl Med. 2023 Aug 16;21(1):551. doi: 10.1186/s12967-023-04418-7. J Transl Med. 2023. PMID: 37587450 Free PMC article. Review.
-
The multidisciplinary approach to eosinophilia.Front Oncol. 2023 May 18;13:1193730. doi: 10.3389/fonc.2023.1193730. eCollection 2023. Front Oncol. 2023. PMID: 37274287 Free PMC article. Review.
References
-
- Motz GT, Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol. 2011;11(10):702–711. - PubMed
-
- Hu G, Wang S, Cheng P. Tumor-infiltrating tryptase(+) mast cells predict unfavorable clinical outcome in solid tumors. Int J Cancer. 2018;142(4):813–821. - PubMed
-
- Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38(5):709–750. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
